Nexo Therapeutics
Rhamy Zeid is currently the VP, Head of Biology at nexo therapeutics. Prior to this, Zeid held positions at Nested Therapeutics as Senior Director, Head of Discovery Biology, and at C4 Therapeutics, Inc. as Director, Target Biology. Zeid's career began at EMD Serono, Inc. as a Research Associate and has since progressed to various roles in the field of biology. Zeid completed a Ph.D. in 2016 from Harvard Medical School after earning a Bachelor's Degree in Biology from Northeastern University.
Nexo Therapeutics
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.